Gemcitabine+nab-paclitaxel併用術前化学療法によりpathological complete responseが得られ根治的切除が可能であった下大静脈浸潤を伴う膵頭部癌の1例-Reference-Cited by-同舟云学术

Gemcitabine+nab-paclitaxel併用術前化学療法によりpathological complete responseが得られ根治的切除が可能であった下大静脈浸潤を伴う膵頭部癌の1例

Published:2023-03-01 Issue:3 Volume:56 Page:165-172
ISSN:0386-9768
Container-title:The Japanese Journal of Gastroenterological Surgery
language:en
Short-container-title:Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi

Author:

Hattori Sakurako¹,Okazaki Sayano¹,Taguchi Keisuke¹,Suematsu Yuki¹,Takahashi Miyuki¹,Fukahori Michiko¹,Teranishi Nobuhisa¹,Wakabayashi Kazuhiko¹,Hirano Kazuhiko²,Shimoyamada Hiroaki²,Yamada Kazuaki²,Ito Yutaka¹

Affiliation:

1. Department of Surgery, National Disaster Medical Center

2. Department of Pathology, National Disaster Medical Center

Publisher

The Japanese Journal of Gastroenterological Surgery

Subject

Gastroenterology,Surgery

Link

https://www.jstage.jst.go.jp/article/jjgs/56/3/56_2021.0011/_pdf

Reference26 articles.

1. 1) NCCN Clinical Practice guidelines in Oncology, Pancreatic adenocarcinoma Version 1 [Internet]. [place unknown]: National Comprehensive Cancer Network; [cited 2020 Oct 23]. Available from: https://www2.tri-kobe.org/nccn/guideline/pancreas/english/pancreatic.pdf/.

2. 2) Mizumoto T, Goto T, Toyama H, Sofue K, Asari S, Terai S, et al. Pancreatic ductal adenocarcinoma with inferior vena cava invasion: a report of three resected cases. Surg Case Rep. 2017;3:72.

3. 3) 北川裕久．膵癌取扱い規約第7版の解説と主な変更点　3．切除可能性分類について．膵臓．2016;31:799–804.

4. 4) 後藤直大，山崎隆，川島龍樹，古出隆大，安田貴志，千堂宏義，ほか．下大静脈浸潤を伴う膵頭部癌に対して膵頭十二指腸切除術を施行した1例．癌と化学療法．2020;47:634–636.

5. 5) 岡田昌義．大静脈の血行再建術における要点とpitfall．脈管学．2005;45:1011–1018.